Critical Care

official impact factor 4.60

Highly Access

Drotrecogin alfa (activated): does current evidence support treatment for any patients with severe sepsis?

Jan O Friedrich*, Neill KJ Adhikari and Maureen O Meade

Critical Care 2006, 10:145 doi:10.1186/cc4947


See related letter by Agarwal and Nath, http://ccforum.com/content/10/4/416, related reply by Friedrich et al., http://ccforum.com/content/10/4/420, related letter by Saxena and Andrews, http://ccforum.com/content/10/5/422, related letter by Williams et al., http://ccforum.com/content/10/5/424, and related reply by Friedrich et al., http://ccforum.com/content/10/6/427

Accesses  

  • Last 30 days: 25 accesses
  • Last 365 days: 441 accesses
  • All time: 5928 accesses